Medical Cannabis Advocacy in the Middle East During the 1960s
How basic science in Israel became confused with a medical movement that never existed.
The 1960s Middle East saw one major scientific breakthrough—Raphael Mechoulam's team isolating THC and CBD in Israel—but no organized medical cannabis advocacy. Most governments in the region remained strictly prohibitionist. Modern cannabis media sometimes projects Israeli research prominence backwards, creating a false narrative of a 'golden age' of medical enlightenment that never happened.
Cannabis prohibition solidifies in the region before 1960
By the early twentieth century, Middle Eastern governments had begun moving decisively against cannabis, despite its centuries of use in the Bekaa Valley and parts of Egypt. Egypt was particularly aggressive internationally, having lobbied the League of Nations in the 1920s to place cannabis on controlled substances lists Strong evidence[1]. In 1961, the 1961 Single Convention on Narcotic Drugs placed cannabis in the most restrictive schedules (Schedules I and IV) Strong evidence[2]. Most Middle Eastern states signed or acceded to this treaty, legally cementing cannabis as a controlled substance rather than a medicine. When the 1960s opened, the regional policy framework was already hostile to any medical or research use—cannabis was defined as a vice and a policing problem, not a therapeutic agent.
The Weizmann Institute breakthrough: real science, not advocacy
The most consequential cannabis story of the 1960s Middle East was scientific rather than political. In 1963, Raphael Mechoulam and Yuval Shvo, working at the Weizmann Institute in Rehovot, Israel, published the structure of cannabidiol (CBD) Strong evidence[3]. One year later, Yechiel Gaoni and Mechoulam isolated and characterized Δ⁹-tetrahydrocannabinol (THC), identifying it as the principal psychoactive constituent of cannabis Strong evidence[4].
Throughout the remainder of the decade, Mechoulam's group clarified the structures of additional cannabinoids and collaborated with pharmacologist Habib Edery on preliminary animal pharmacology studies. By 1967, they reported the first total synthesis of THC Strong evidence, a milestone that enabled broader research into cannabinoid mechanism and effects.
Mechoulam and his colleagues openly framed this work as medically motivated—they argued in print that morphine and cocaine had been systematically isolated from their source plants over a century earlier, and that cannabis deserved the same rigorous chemical and pharmacological attention [4]. However, this was basic chemistry and pharmacology, not clinical advocacy or public campaigns for legalization or therapeutic use. The work laid the scientific foundation for every later medical-cannabis research program in the world, but it operated within the legal and institutional boundaries of academic laboratory research, not as part of an organized movement.
Was there organized medical advocacy? The evidence says no
If 'advocacy' means organized public or professional campaigns to legalize, normalize, or promote the medical use of cannabis in the 1960s Middle East, the historical record shows essentially none Weak / limited. This absence is notable given the legal and political context:
- Egypt maintained an official prohibitionist stance throughout the decade, with cannabis framed as a social problem. Law enforcement and public health messaging focused on harm, not potential benefits.
- Lebanon attempted periodic eradication campaigns in the Bekaa Valley, though with limited success against entrenched cultivation.
- Iran, often grouped with the region in discussions of drug policy, executed drug traffickers under the Shah's stringent narcotics laws.
What did exist were three narrower forms of professional engagement:
Scientific research: Mechoulam's team in Israel operated openly with medical motivation, but within the bounds of basic laboratory research, not public advocacy.
Clinical observation: Egyptian and Lebanese psychiatrists, including M. I. Soueif, published case reports and epidemiological studies on cannabis (hashish) use. Soueif's work beginning in the late 1960s studied cognitive and behavioral effects in chronic users, primarily drawn from prison populations—the framing was clinical documentation of harm rather than therapeutic potential Strong evidence[6].
Informal medical use: Folk and traditional medicine practices involving cannabis preparations continued in rural areas, particularly in the Levant and Iran. This represented continuity of customary practice, not organized medical advocacy Weak / limited.
How the mythology of a 1960s 'golden age' developed
Modern cannabis advocacy and media sometimes present the 1960s Middle East—particularly Israel—as a golden age of medical-cannabis enlightenment. This narrative does not fit the historical evidence. The myth appears to have grown from three overlapping sources:
Retroactive projection of Israeli research prominence: Once Israel became a world leader in medical-cannabis research, export, and clinical development in the 2000s and 2010s, journalists and advocates projected that contemporary prominence backward onto the 1960s. Mechoulam's work was real and groundbreaking; the surrounding 'medical-cannabis movement' was not Weak / limited[7].
Conflation with Western drug culture: Lebanese hashish—particularly the 'Red' and 'Blonde' varieties—became iconic in 1960s European and American counterculture. This cultural visibility retrospectively glamorized Middle Eastern production as a tacit endorsement of cannabis. In reality, the producers were farmers and smugglers operating within a legal and commercial framework, not advocates for medical legitimacy Anecdote.
Romanticized readings of historical medicine: Older Arabic and Persian medical texts reference cannabis (qinnab, bhang) in therapeutic contexts, drawing on centuries of Unani and Ayurvedic medical traditions. These historical citations are sometimes quoted as evidence of a living 1960s medical tradition—they were not Disputed[8]. The texts document pre-prohibition medical use; they do not describe an organized clinical or advocacy movement in the twentieth century.
Timeline of documented events, 1961–1969
- 1961: The 1961 Single Convention on Narcotic Drugs is adopted by the United Nations, placing cannabis in Schedules I and IV. Most Middle Eastern and global states sign or accede [2].
- 1963: Mechoulam and Shvo publish the chemical structure of cannabidiol (CBD) in Tetrahedron [3].
- 1964: Gaoni and Mechoulam publish the isolation, characterization, and partial synthesis of Δ⁹-THC in the Journal of the American Chemical Society [4].
- Mid-1960s: Lebanese government conducts intermittent eradication campaigns in the Bekaa Valley, with limited practical effect on production.
- 1967: Mechoulam's group reports the first total synthesis of THC, enabling broader pharmacological experimentation.
- Late 1960s: M. I. Soueif initiates systematic behavioral and cognitive studies of chronic hashish users in Egyptian prisons, published throughout the 1970s [6].
What the historical record actually shows
The honest picture is this: the 1960s Middle East was the birthplace of modern cannabinoid chemistry, accomplished almost entirely through one Israeli laboratory with material sourced from official police channels. It was not the birthplace of a medical cannabis advocacy movement. That kind of organized advocacy—combining scientific evidence, patient testimony, legal reform campaigns, and public policy engagement—is largely a phenomenon of the 1990s onward, emerging primarily in North America (the United States and Canada), the Netherlands, and eventually Israel itself.
Mechoulam's work was essential to modern medical cannabis: it gave researchers the chemical and pharmacological tools to study cannabis rationally, rather than as folklore or folk medicine. But the work existed in a geopolitical and legal context of strict prohibition. To conflate basic laboratory research with organized medical or social advocacy is to misread both history and the nature of scientific institutions under prohibitionist law.
Anyone who tells you otherwise is trading in a tidier, more heroic narrative than the evidence supports.
Sources
- Peer-reviewed Kozma, L. (2011). Cannabis prohibition in Egypt, 1880–1939: From local ban to League of Nations diplomacy. Middle Eastern Studies, 47(3), 443–460.
- Government United Nations. (1961). Single Convention on Narcotic Drugs, 1961. Treaty Series 520.
- Peer-reviewed Mechoulam, R., & Shvo, Y. (1963). Hashish—I: The structure of cannabidiol. Tetrahedron, 19(12), 2073–2078.
- Peer-reviewed Gaoni, Y., & Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society, 86(8), 1646–1647.
- Peer-reviewed Soueif, M. I. (1971). The use of cannabis in Egypt: A behavioural study. Bulletin on Narcotics, 23(4), 17–28.
- Peer-reviewed Mechoulam, R., Braun, P., & Gaoni, Y. (1967). A stereospecific synthesis of (-)-Δ¹- and (-)-Δ¹(⁶)-tetrahydrocannabinols. Journal of the American Chemical Society, 89(17), 4552–4554.
- Peer-reviewed Mechoulam, R. (2019). A delightful trip along the pathway of cannabinoid and endocannabinoid chemistry and pharmacology. Annual Review of Pharmacology and Toxicology, 59, 1–13.
- Reported Pollan, M. (2019, May 14). The grandfather of cannabis research: Profile of Raphael Mechoulam. The New York Times Magazine.
- Book Russo, E. B. (2007). History of cannabis and its preparations in saga, science, and sobriquet. Chemistry & Biodiversity, 4(8), 1614–1648.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- 1960s Counterculture and Cannabis — Cannabis as symbol and practice in the American counterculture, 1960–1972.
- 1961 Single Convention on Narcotic Drugs — The UN treaty that unified international drug control and shaped cannabis prohibition glob...
- Cannabis in Cinema, 1930s–1960s — From exploitation propaganda to counterculture symbol: how cannabis appeared on American s...
- UN Drug Treaties and Cannabis — Three UN treaties control cannabis globally; legalization exists despite treaty language f...